retatrutide triple agonist glp-1 gip glucagon ly3437943 (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results LY3437943 in healthy participants in
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6























